Supplementary Tables S1-S4 from Suppression of Deacetylase SIRT1 Mediates Tumor-Suppressive NOTCH Response and Offers a Novel Treatment Option in Metastatic Ewing Sarcoma

Ban, Jozef; Aryee, Dave N.T.; Fourtouna, Argyro; van der Ent, Wietske; Kauer, Max; Niedan, Stephan; Machado, Isidro; Rodriguez-Galindo, Carlos; Tirado, Oscar M.; Schwentner, Raphaela; Picci, Piero; Flanagan, Adrienne M.; Berg, Verena; Strauss, Sandra J.; Scotlandi, Katia; Lawlor, Elizabeth R.; Snaar-Jagalska, Ewa; Llombart-Bosch, Antonio; Kovar, Heinrich

doi:10.1158/0008-5472.22404536.v1

00085472can141736-sup-133046_1_supp_0_nc1qlg.docx (95.64 kB)

Supplementary Tables S1-S4 from Suppression of Deacetylase SIRT1 Mediates Tumor-Suppressive NOTCH Response and Offers a Novel Treatment Option in Metastatic Ewing Sarcoma

journal contribution

posted on 2023-03-30, 22:52 authored by Jozef Ban, Dave N.T. Aryee, Argyro Fourtouna, Wietske van der Ent, Max Kauer, Stephan Niedan, Isidro Machado, Carlos Rodriguez-Galindo, Oscar M. Tirado, Raphaela Schwentner, Piero Picci, Adrienne M. Flanagan, Verena Berg, Sandra J. Strauss, Katia Scotlandi, Elizabeth R. Lawlor, Ewa Snaar-Jagalska, Antonio Llombart-Bosch, Heinrich Kovar

Supplementary Tables S1-S4. Identification of HEY1 regulated genes downstream of EWS-FLI1 silencing in Ewing sarcoma (S1); Combined immunohistochemical staining results for samples from patients with metastases at diagnosis on TMA1 and 2 according to site of metastasis (S2); Clinical characteristics and SIRT1 staining results of primary tumors from 43 ES patients treated at St. Jude Children´s Hospital between 1979 and 1987 using vincristine, doxorubicin, and cyclophosphamide-based regimens, with subsequent addition of ifosfamide and etoposide (S3); Materials used in the study (S4).

History

ARTICLE ABSTRACT

The developmental receptor NOTCH plays an important role in various human cancers as a consequence of oncogenic mutations. Here we describe a novel mechanism of NOTCH-induced tumor suppression involving modulation of the deacetylase SIRT1, providing a rationale for the use of SIRT1 inhibitors to treat cancers where this mechanism is inactivated because of SIRT1 overexpression. In Ewing sarcoma cells, NOTCH signaling is abrogated by the driver oncogene EWS-FLI1. Restoration of NOTCH signaling caused growth arrest due to activation of the NOTCH effector HEY1, directly suppressing SIRT1 and thereby activating p53. This mechanism of tumor suppression was validated in Ewing sarcoma cells, B-cell tumors, and human keratinocytes where NOTCH dysregulation has been implicated pathogenically. Notably, the SIRT1/2 inhibitor Tenovin-6 killed Ewing sarcoma cells in vitro and prohibited tumor growth and spread in an established xenograft model in zebrafish. Using immunohistochemistry to analyze primary tissue specimens, we found that high SIRT1 expression was associated with Ewing sarcoma metastasis and poor prognosis. Our findings suggest a mechanistic rationale for the use of SIRT1 inhibitors being developed to treat metastatic disease in patients with Ewing sarcoma. Cancer Res; 74(22); 6578–88. ©2014 AACR.